Effectiveness and safety of IV rt-PA treatment in Chinese AIS patients aged above 80 years: a real-world study (0135-0349)

Study identification

• EU PAS number:
  EUPAS41540
• Study ID:
  48055
• Official title and acronym:
  Effectiveness and safety of IV rt-PA treatment in Chinese AIS patients aged above 80 years: a real-world study (0135-0349)
• DARWIN EU® study:
  No
• Study countries:
  China
• Study description:
  Alteplase treatment in elderly AIS patients
• Study status:
  Planned

Research institutions and networks

Institutions

Zhejiang University

The Second Affiliated Hospital,School of Medicine

Study timelines

Date when funding contract was signed

Planned:01/08/2021

Actual:18/08/2021

Study start date

Planned:01/12/2022

Date of final study report

Planned:30/12/2023

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Boehringer Ingelheim Int’l Trading (Shanghai) Co., Ltd

Regulatory

• Was the study required by a regulatory body?:
  Unknown
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable